Literature DB >> 8207844

Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency.

W R Green1, K A Green, K M Crassi.   

Abstract

Cytolytic T lymphocytes (CTL) can be raised against C57BL/6 B-cell lymphomas from mice with LP-BM5 murine leukemia virus-induced AIDS (MAIDS). Adoptive transfer of polyclonal anti-MAIDS tumor CTL or two CTL clones specific for the B6-1710 MAIDS lymphoma caused preservation of major histocompatibility complex-restricted and allogeneic CTL responses, which may be interpreted as indices of protection from LP-BM5 murine leukemia virus-induced immunodeficiency.

Entities:  

Mesh：

Year:  1994        PMID： 8207844      PMCID： PMC236398     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  36 in total

1.  GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS.

Authors:  F LILLY; E A BOYSE; L J OLD
Journal:  Lancet       Date:  1964-12-05       Impact factor: 79.321

2.  Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.

Authors:  W R Green; R C Nowinski; C S Henney
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

3.  Characteristics of the cell populations involved in extra-thymic lymphosarcoma induced in C57BL/6 mice by RadLV-Rs.

Authors:  E Legrand; R Daculsi; J F Duplan
Journal:  Leuk Res       Date:  1981       Impact factor: 3.156

4.  The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.

Authors:  W R Green; R C Nowinski; C S Henney
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

5.  Reticulum cell neoplasms induced in C57BL/6 mice by cultured virus grown in stromal hematopoietic cell lines.

Authors:  M Haas; A Meshorer
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

6.  Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly.

Authors:  B Chesebro; K Wehrly
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

7.  Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV).

Authors:  P K Pattengale; C R Taylor; P Twomey; S Hill; J Jonasson; T Beardsley; M Haas
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

8.  The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.

Authors:  W R Green
Journal:  Eur J Immunol       Date:  1983-11       Impact factor: 5.532

9.  H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus.

Authors:  W J Britt; B Chesebro
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.

Authors:  B Chesebro; K Wehrly; J Stimpfling
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307
View more
  3 in total

1.  Immunotherapy of murine retrovirus-induced acquired immunodeficiency by CD4 T regulatory cell depletion and PD-1 blockade.

Authors:  Wen Li; William R Green
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

2.  Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.

Authors:  K A Green; K M Crassi; J D Laman; A Schoneveld; R R Strawbridge; T M Foy; R J Noelle; W R Green
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  In vivo effects of locally secreted IL-10 on the murine antitumor immune response.

Authors:  R J Barth; M A Coppola; W R Green
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.